Skip to main content
Log in

Comparing costs of HSCT in leukaemia: RIC vs MAC

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Suh KJ, et al. Total costs and clinical outcome of hematopoietic stem cell transplantation in adults with leukemia: comparison between reduced-intensity and myeloablative conditioning. Clinical Transplantation : 27 Nov 2014. Available from: URL: http://doi.org/10.1111/ctr.12492

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Comparing costs of HSCT in leukaemia: RIC vs MAC. PharmacoEcon Outcomes News 718, 17 (2014). https://doi.org/10.1007/s40274-014-1782-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1782-2

Navigation